Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20120922010900N5Phase 3Completed
Phase 3, double-blind trial of duloxetine in postoperative pain (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Pain intensity in recovery, Analgesic consumption in first 24 hours and 3 more. Started Feb 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20120922010900N5.